FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a method for preparing diastereomer pure dibenzoyl-L-tartrate salt of formula (III) involving the stages: (a) mixing a compound of formula (II) with enantiomer pure dibenzoyl-L-tartaric acid or its monohydrate to form diastereoisomer salt wherein the solvent represents a mixture of water and ethanol; and (b) crystallising said salt, as well as mono-dibenzoyl-L-tartrate salt of formula (III) which is an intermediate product in synthesis of (lS-[1α,2α,3β(1S*,2R*),5β]}-3(7-{[2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)-cyclopentane-1,2-diol which possess antithrombotic action.
EFFECT: preparing the compound which possess antithrombotic action.
2 cl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING BENZYL-[(3aS, 4R, 6S, 6aR)-6-HYDROXY-2, 2-DIMETHYLTETRAHYDRO-3aN-CYCLOPENTA[d][1,3]DIOXOL-4-YL]CARBAMATE AND INTERMEDIATE COMPOUNDS IN SAID METHOD | 2012 |
|
RU2588673C2 |
METHOD FOR OBTAINING [1S-[1α,2α,3β(1S*,2R*),5β]]-3-[7-[2-(3,4-DIFLUOROPHENYL)-CYCLOPROPYLAMINO]-5-(PROPYLTHIO)-3H-1,2,3-TRIAZOLO[4;5-d]PYRIMIDINE-3-YL]-5-(2-HYDROXYETHOXY)-CYCLOPENTANE-1,2-DIOL AND ITS INTERMEDIATE COMPOUNDS | 2009 |
|
RU2509082C2 |
RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS | 2011 |
|
RU2606514C2 |
COMPOSITIONS AND METHODS FOR INHIBITING VIRAL POLYMERASE | 2013 |
|
RU2654482C2 |
PYRIMIDINE COMPOUNDS, METHODS FOR THEIR PREPARING (VARIANTS), INTERMEDIATE SUBSTANCES (VARIANTS) AND METHODS FOR THEIR PREPARING (VARIANTS), METHOD FOR PREPARING TRIAZOLOPYRIMIDINE COMPOUNDS | 2001 |
|
RU2295526C2 |
METHOD FOR PRODUCTION OF (3R, 3aS,6aR)-HEXAHYDROFURO[2,3-b]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1- BENZYL-2-HYDROXYPROPYLURETHANE | 2004 |
|
RU2376308C2 |
COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
COMPOUNDS WHICH ARE ANTAGONISTS OF THE A3-ADENOSINE RECEPTOR, A METHOD FOR PREPARING THEM AND MEDICAL USE THEREOF | 2017 |
|
RU2737157C2 |
NEW PYRROLOPYRIMIDINE COMPOUND OR ITS SALT, PHARMACEUTICAL COMPOSITION CONTAINING IT, IN PARTICULAR, AGENT FOR PREVENTION AND / OR TREATMENT OF TUMORS AND SO ON, BASED ON INHIBITING INFLUENCE ON NAE | 2015 |
|
RU2658008C2 |
Authors
Dates
2013-03-10—Published
2008-11-14—Filed